LEI NIE to Protein Kinase Inhibitors
This is a "connection" page, showing publications LEI NIE has written about Protein Kinase Inhibitors.
Connection Strength
0.081
-
Targeting PKCd as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer. Cancer Cell. 2018 12 10; 34(6):954-969.e4.
Score: 0.053
-
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma. J Clin Invest. 2023 02 01; 133(3).
Score: 0.018
-
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia. Clin Cancer Res. 2015 Aug 15; 21(16):3586-90.
Score: 0.011